Research Facilities
Cancer Institute (WIA) provides researchers with access to state-of-the-art infrastructure spanning core instrumentation, GMP manufacturing, clinical trials, biobanking, and preclinical disease modeling — enabling translational cancer research from bench to bedside.
Core Research Equipment
Centralized instrumentation facility housing advanced sequencing, flow cytometry, microscopy, and molecular biology platforms for translational cancer research.
Learn more
GMP Manufacturing Facility
Good Manufacturing Practice facility dedicated to producing cell-based therapies and immunotherapeutics under regulatory-compliant conditions.
Learn more
Clinical Trials Unit
Dedicated infrastructure for conducting Phase I through Phase III clinical trials with GCP-compliant protocols and integrated research pharmacy services.
Learn more
Biorepository & Tissue Bank
Centralized repository of annotated tumor tissues, blood samples, and biofluids supporting translational research across multiple cancer types.
Learn more
Preclinical Disease Models
Preclinical modeling platform supporting in vitro and in vivo studies for drug efficacy testing and mechanistic cancer research.
Learn more